Primary Use: Prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness and vestibular disturbances
Benefits
Used in the prevention and treatment of motion sickness by reducing nausea, vomiting, and dizziness associated with travel
Used in the management of vertigo and vestibular disturbances to alleviate associated discomfort and imbalance symptoms
Used for symptomatic relief in pregnancy-related nausea under medical guidance
How to Use
Disclaimer: This product is a prescription-only medicine and must be used strictly under the supervision of a licensed healthcare professional. Always adhere to the directions provided on the prescription label. Consult your doctor if you have any questions or concerns regarding its use.
Description
Vominore 25 mg/50 mg Tablets are a prescription antiemetic medication formulated with a combination of meclizine hydrochloride 25 mg and pyridoxine hydrochloride 50 mg, designed to help prevent and manage nausea, vomiting, and dizziness arising from motion sickness, vestibular imbalance, or other causes. This combination makes Vominore suitable for motion sickness prevention, such as during travel or sea trips, as well as for relief from dizziness and vertigo symptoms associated with inner ear disturbances. In some cases, clinicians may consider its use for nausea related to pregnancy or other conditions, although use during pregnancy should always be under medical supervision. The typical administration involves taking the tablet orally before exposure to the nausea-inducing situation (e.g., before travel) or as directed by a healthcare professional.